Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis. [electronic resource]
Producer: 20050426Description: 78-85 p. digitalISSN:- 0378-5122
- Administration, Cutaneous
- Aged
- Alkaline Phosphatase -- blood
- Biomarkers -- analysis
- Bone Density
- Collagen -- urine
- Contraceptives, Oral, Synthetic -- therapeutic use
- Double-Blind Method
- Estradiol -- therapeutic use
- Estrogen Replacement Therapy
- Female
- Humans
- Levonorgestrel -- therapeutic use
- Middle Aged
- Osteocalcin -- blood
- Osteoporosis, Postmenopausal -- prevention & control
- Peptide Fragments -- urine
- Prospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.